Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

American Capital Agency Corp. (AGNC) Earnings: An Early Look

Earnings season is in full swing, with many companies having already given their latest numbers to investors. The key to making smart investment decisions with stocks releasing their quarterly reports is to anticipate how they’ll do before they announce results, leaving you fully prepared to respond quickly to whatever inevitable surprises arise. That way, you’ll be less likely to make an uninformed knee-jerk reaction to news.

American Capital Agency Corp. (NASDAQ:AGNC)Let’s turn to American Capital Agency Corp. (NASDAQ:AGNC). The mortgage REIT has been at the top of the dividend-yield charts for years, but competition for mortgage-backed securities from the Federal Reserve has pulled payouts down and cast doubts on the viability of the industry going forward. Let’s take an early look at what’s been happening with American Capital Agency over the past quarter and what we’re likely to see in its quarterly report on Thursday.

Stats on American Capital Agency Corp. (NASDAQ:AGNC)

Analyst EPS Estimate $1.06
Change From Year-Ago EPS 7%
Revenue Estimate $382 million
Change From Year-Ago Revenue 45%

Source: S&P Capital IQ.

Will American Capital Agency keep on paying off investors?
Trying to come up with estimates for American Capital Agency is always difficult, as so many variables go toward producing bottom-line earnings for mortgage REITs. With elements like derivative exposure and sales of assets having an impact on total revenue figures, net interest income is arguably a better measure of overall success, and it appears likely to climb as well. Yet even after factoring in a dividend payment, American Capital Agency has produced only flat returns since early November.

For years, low interest rates bolstered prospects for American Capital Agency and its mortgage REIT peers. By borrowing cheaply and investing in higher-yielding mortgage-backed securities, American Capital Agency was able to generate and sustain double-digit dividend yields, taking advantage of REIT status to avoid corporate-level taxation on its profits.

Now, though, the mortgage REIT space has gotten extremely crowded. American Capital Agency and rival Annaly Capital Management, Inc. (NYSE:NLY) dwarf the other players in the industry, but ARMOUR Residential REIT, Inc. (NYSE:ARR) and CYS Investments Inc (NYSE:CYS) are among many small companies that have been fighting over a dwindling supply of potential investment securities. Moreover, since the Federal Reserve has bought nearly $1 trillion in mortgage-backed securities as part of its QE3 strategy, American Capital Agency and its peers have had even fewer securities to buy. That’s one reason why Annaly is buying Crexus Investment Corp (NYSE:CXS) , but it also has contributed to the trend toward lower dividends among mortgage REIT players.

In American Capital Agency’s report, be on the lookout for further news about future strategic plans, including investment policy and potential acquisitions. As it gets harder for the REIT to obtain the securities it needs, American Capital Agency could have no choice but to retrench and prepare for potentially higher interest rates in the future.

The article American Capital Agency Earnings: An Early Look originally appeared on and is written by Dan Caplinger.

Fool contributor Dan Caplinger has no position in any stocks mentioned. You can follow him on Twitter @DanCaplinger. The Motley Fool owns shares of Annaly Capital Management (NYSE:NLY).

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!